Reaction
Catheter Management reporting signals
As of the last recalculation, Catheter Management appears in 891 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 2,268.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 524 | 2,268.8 | 2,364.0 |
| Macitentan | 335 | 180.5 | 181.4 |
| Sildenafil | 173 | 86.3 | 86.6 |
| Sildenafil Powder, | 110 | 82.2 | 82.5 |
| Riociguat | 98 | 78.8 | 79.0 |
| Sildenafil Citrate | 279 | 74.1 | 74.2 |
| Tadalafil | 232 | 72.8 | 73.0 |
| Bosentan | 104 | 54.4 | 54.5 |
| Selexipag | 55 | 52.9 | 53.0 |
| Treprostinil | 183 | 42.6 | 42.7 |
| 0Xygen | 66 | 33.7 | 33.8 |
| Oxygen | 66 | 33.7 | 33.8 |
| Ambrisentan | 145 | 32.2 | 32.2 |
| Metolazone | 12 | 25.3 | 25.3 |
| Warfarin | 84 | 17.0 | 17.0 |
| Niraparib | 12 | 12.8 | 12.8 |
| Tolvaptan | 6 | 9.7 | 9.7 |